Francis Le is a Cardiology physician. OpenAlex indexes 17 publications with 622 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1834 Lisenby Ave
Panama City, FL 324053761
Telephone
850-215-6008Provider last certified this registry record 11 Mar 2026.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20251 payment
- Boston Scientific CorporationProgram year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.2%Beta blocker28.5%Carvedilol63%Metoprolol Succinate37%Part D≥36 patientsStatin16.8%Atorvastatin Calcium51%Rosuvastatin Calcium49%Part D≥16 patients+ 6 more classes in this area
Blood & clotting
12.7%Factor Xa inhibitor6.7%Eliquis100%Part D≥13 patientsP2Y12 inhibitor6%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
3.1%Potassium supplement3.1%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Meta-analysis of Clinical Trials Evaluating the Impact of Bivalirudin-based Anticoagulation for Primary Percutaneous Coronary on Long-Term Mortality
Journal of Cardiovascular Pharmacology
2021 - Increased risk of stent thrombosis with use of a direct oral anticoagulant and a single antiplatelet agent after <scp>PCI</scp>: A meta‐analysis
Catheterization and Cardiovascular Interventions
2020 - Recette et déploiement de l'outil LDD+
HAL (Le Centre pour la Communication Scientifique Directe)
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”